Biointron @Biointron2012

Founded in 2012, we are a biotechnology CRO with expertise in antibody discovery. We have served biotech/biopharma companies worldwide. biointron.com Shanghai/China, New Jersey/US Joined April 2023

Tweets

800
Followers

40
Following

58
Likes

115

Biointron @Biointron2012

2 days ago

🎯 A new study published in @SciReports uses computer simulations to study the “bystander effect” of ADCs, in which nearby cancer cells are also affected by passive diffusion. nature.com/articles/s4159… nature.com/articles/s4159…

0 0 0 1 0

Biointron @Biointron2012

3 days ago

Read the latest on the landscape of #multispecific #antibody platforms from Biointron Monthly: biointron.com/antibody-indus… biointron.com/antibody-indus…

0 0 0 5 0

Biointron @Biointron2012

4 days ago

🎙️ Listen to Episode 8 of Biointron’s Spotlight on Antibodies! This August, we highlight drug advances in autoimmune and infectious diseases, as well as next-generation immune cell engagers. 🔗 creators.spotify.com/pod/profile/bi… creators.spotify.com/pod/profile/bi…

0 0 0 5 0

Biointron @Biointron2012

a week ago

🦠 𝗡𝗲𝘄 𝗛𝗼𝗽𝗲 𝗳𝗼𝗿 𝗠𝗽𝗼𝘅 𝗮𝗻𝗱 𝗢𝗿𝘁𝗵𝗼𝗽𝗼𝘅𝘃𝗶𝗿𝘂𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 @IcahnMountSinai researchers has identified human monoclonal antibodies (mAbs) targeting the A35 protein of monkeypox virus (MPXV) cell.com/cell/fulltext/… cell.com/cell/fulltext/…

0 0 0 7 0

Biointron @Biointron2012

a week ago

Study led by @Cornell sets the stage for using E. coli to produce fully human antibodies! Read the full paper here 👉 nature.com/articles/s4146… nature.com/articles/s4146…

0 1 0 126 0

Biointron @Biointron2012

2 weeks ago

🌟 𝗢𝘂𝗿 𝗹𝗮𝘁𝗲𝘀𝘁 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗱𝗲𝗹𝘃𝗲𝘀 𝗶𝗻𝘁𝗼 𝗙𝗰 𝗴𝗹𝘆𝗰𝗮𝗻𝘀 𝗮𝗻𝗱 𝗮𝗳𝘂𝗰𝗼𝘀𝘆𝗹𝗮𝘁𝗲𝗱 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 💡 biointron.com/blog/role-of-f… #Biointron #DrugDevelopment #Healthcare #Antibodies #DrugDiscovery biointron.com/blog/afucosyla…

0 0 0 1 0

Biointron @Biointron2012

2 weeks ago

A citrullinated histone H3 monoclonal antibody for immune modulation in sepsis Study by @UVA and @UMich. Sepsis remains a major global health challenge, driven by uncontrolled inflammation and immune dysfunction. nature.com/articles/s4146… nature.com/articles/s4146…

0 0 0 7 0

Biointron @Biointron2012

3 weeks ago

𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗕𝗶𝗼𝗶𝗻𝘁𝗿𝗼𝗻 & 𝗞𝗮𝗰𝘁𝘂𝘀 𝟮𝟬𝟮𝟱 𝗟𝘂𝗻𝗰𝗵 & 𝗟𝗲𝗮𝗿𝗻 𝗶𝗻 𝗖𝗮𝗺𝗯𝗿𝗶𝗱𝗴𝗲, 𝗠𝗔! eventbrite.com/e/biointron-ka… eventbrite.com/e/biointron-ka…

0 0 0 6 0

Biointron @Biointron2012

3 weeks ago

𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀 𝗳𝗼𝗿 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 🦠 Researchers from @UBC outline some of the challenges in developing antibodies rapidly in response to pandemic threats. pubs.acs.org/doi/full/10.10… pubs.acs.org/doi/full/10.10…

0 0 0 12 0

Biointron @Biointron2012

4 weeks ago

🎉 𝗕𝗶𝗼𝗶𝗻𝘁𝗿𝗼𝗻 𝗥𝗲𝗮𝗰𝗵𝗲𝘀 𝟮,𝟱𝟬𝟬+ 𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀 𝗪𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲! 💬 Hear from our partners: Explore real stories from clients who have experienced Biointron’s technical excellence and collaborative approach → biointron.com/testimonials

0 0 0 9 0

Download Image

Biointron @Biointron2012

4 weeks ago

While the United States continues to lead in first-in-class drugs, China has transformed from a generics-heavy market into a serious developer of biologics, cell therapies, and gene therapies in just a few years. nature.com/articles/s4139… nature.com/articles/s4139…